HMTM-Mediated Enhancement of Brain Bioenergetics in a Mouse Tauopathy Model Is Blocked by Chronic Administration of Rivastigmine.

At a dose of 15 mg/kg, HMTM increased complex I activity normalised to citrate synthase levels, although the increase did not reach statistical significance ( Figure 3 A).

also in 111,027 other papers